Neuraxpharm Parts Company With API Subsidiary Inke
Firm Says Divestiture Will Allow It To Sharpen Focus On CNS Business
In light of its ongoing focus on European expansion and a desire to sharpen concentration on its central CNS business, Neuraxpharm has opted to divest its API subsidiary Inke to a private equity firm.
